Surgery Partners, INC Form 4 insider transactions

Director Brent Turner acquired 6,170 shares of Surgery Partners, Inc. on June 6, 2024, at a price of $25.93 per share.

Director John A. Deane acquired 6,170 shares of Surgery Partners, Inc. at a price of $25.93 on June 6, 2024.

Clifford G. Adlerz, a director at Surgery Partners, Inc., acquired 6,170 shares of common stock at a price of $25.93 per share on June 6, 2024.

Director Teresa DeLuca acquired 6,170 shares of Surgery Partners, Inc. common stock on June 6, 2024, at a price of $25.93 per share.

Bradley R. Owens, National Group President of Surgery Partners, Inc., sold 6,000 shares of common stock at a weighted average price of $27.65 on May 31, 2024.

Director Brent Turner acquired 4,192 shares of Surgery Partners, Inc. common stock at a price of $38.16 per share on June 1, 2023.

Director Teresa DeLuca acquired 4,192 shares of Surgery Partners, Inc. common stock at a price of $38.16 per share on June 1, 2023.

Clifford G. Adlerz, a director at Surgery Partners, Inc., acquired 4,192 shares of common stock at a price of $38.16 on June 1, 2023.

Director John A. Deane acquired 4,192 shares of Surgery Partners, Inc. common stock at a price of $38.16 on June 1, 2023.

Patricia Anne Maryland, a director at Surgery Partners, Inc., acquired 4,192 shares of common stock at a price of $38.16 on June 1, 2023.

David T. Doherty, CFO of Surgery Partners, Inc., sold 721 shares of common stock on March 14, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock.

Surgery Partners CEO Jason Eric Evans sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock.

Bradley R. Owens, National Group President of Surgery Partners, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock.

Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 2,318 shares of common stock on March 4, 2024, to cover tax obligations related to vesting restricted stock.

Bradley R. Owens, National Group President of Surgery Partners, Inc., sold 1,658 shares of common stock on March 4, 2024, to cover tax obligations related to vesting restricted stock.

Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., sold 1,347 shares of common stock on March 5, 2024, to cover tax obligations related to vesting restricted stock.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold 586 shares of common stock on March 4, 2024, to cover tax obligations related to vesting restricted stock.

David T. Doherty, CFO of Surgery Partners, Inc., sold 3,426 shares of common stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock.

Harrison R. Bane, American Group President at Surgery Partners, sold shares of common stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 1,284 shares of common stock on March 4, 2024, to satisfy tax withholding obligations related to vesting restricted stock.

Surgery Partners CEO Jason Eric Evans sold 9,070 shares of common stock on March 4, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., reports acquiring 19,243 shares of restricted stock on February 28, 2024.

Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., was granted restricted stock awards on February 28, 2024, increasing his beneficial ownership in the company.

Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc., reports acquisition of common stock through restricted stock awards.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., acquired shares through restricted stock awards on February 28, 2024.

David T. Doherty, CFO of Surgery Partners, Inc., acquired 25,657 shares of common stock through a restricted stock award on February 28, 2024.

Surgery Partners CEO Jason Eric Evans acquired 56,446 shares of common stock on February 28, 2024, through a restricted stock award.